Anti-Spike and Neutralizing Antibodies after Two Doses of COVID-19 Sinopharm/BIBP Vaccine

Anti-Spike and Neutralizing Antibodies after Two Doses of COVID-19 Sinopharm/BIBP Vaccine

Host response to COVID-19 vaccines is partially evaluated through the estimation of antibody response, specifically the binding anti-spike (anti-S) and the neutralizing antibodies (nAbs) against SARS-CoV-2. Vaccine-induced humoral response affects decisions on the choice of vaccine type, vaccine acc...

Full description

Bibliographic Details
Main Authors: Eman A. Omran, Roaa E. El Naggar, Logina A. Ezz Elarab, Mona H. Hashish, Mohammed A. El-Barrawy, Ibrahim A. Abdelwahab, Marwa M. Fekry
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Vaccines
Subjects:
humoral immunity
neutralizing antibodies
COVID-19 vaccines
SARS-CoV-2
Online Access:https://www.mdpi.com/2076-393X/10/8/1340

Internet

https://www.mdpi.com/2076-393X/10/8/1340

Similar Items